Parliamentary QA
Coverage of Fertility Preservation
8 May 2024
This article has been migrated from an earlier version of the site and may display formatting inconsistencies.
NOTICE PAPER NO. 2756
NOTICE OF QUESTION FOR WRITTEN ANSWER
FOR THE SITTING OF PARLIAMENT ON OR AFTER 8 MAY 2024
Name and Constituency of Member of Parliament
Dr Tan Wu Meng
MP for Jurong GRC
Question No. 5785
To ask the Minister for Health (a) whether the Ministry has evaluated the available healthcare insurance policies in the market, including employer-provided insurance and Integrated Shield Plans, for the extent of coverage of fertility preservation therapy for cancer patients undergoing medically necessary treatment where the side effects may affect fertility; and (b) if so, what have been the findings.
Answer
1 MOH does not evaluate private insurance coverage of fertility preservation therapy, as these are optional products subject to insurers’ commercial considerations.
2 MediShield Life does not cover fertility related treatments as it was designed as a basic health insurance scheme, covering large bills due to treatment of diseases in subsidised public hospitals. Nevertheless, patients can tap on MediSave for fertility treatments, including egg freezing on medical grounds, subject to the assisted reproductive treatment lifetime withdrawal limit of $15,000 per patient.